Cargando…
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Neutralizing antibodies have become an important tool in treating infectious diseases. Recently, two separate approaches yielded successful antibody treatments for Ebola—one from genetically humanized mice and the other from a human survivor. Here, we describe parallel efforts using both humanized m...
Ejemplares similares
-
Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle East Respiratory Syndrome Coronavirus
por: Sivapalasingam, Sumathi, et al.
Publicado: (2021) -
Structural analysis of cancer-relevant TCR-CD3 and peptide-MHC complexes by cryoEM
por: Saotome, Kei, et al.
Publicado: (2023) -
Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants
por: Simões, Eric A F, et al.
Publicado: (2020) -
The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies
por: Copin, Richard, et al.
Publicado: (2021) -
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
por: Baum, Alina, et al.
Publicado: (2020)